Regulatory T cells (T reg cells) are critically involved in maintaining immunological tolerance, but this potent suppression must be 'quenched' to allow the generation of adaptive immune responses. Here we report that sphingosine 1-phosphate (S1P) receptor type 1 (S1P 1 ) delivers an intrinsic negative signal to restrain the thymic generation, peripheral maintenance and suppressive activity of T reg cells. Combining loss-and gain-of-function genetic approaches, we found that S1P 1 blocked the differentiation of thymic T reg precursors and function of mature T reg cells and affected T reg cell-mediated immune tolerance. S1P 1 induced selective activation of the Akt-mTOR kinase pathway to impede the development and function of T reg cells. Dynamic regulation of S1P 1 contributed to lymphocyte priming and immune homeostasis. Thus, by antagonizing T reg cell-mediated immune suppression, the lipid-activated S1P 1 -Akt-mTOR pathway orchestrates adaptive immune responses.
Regulatory T cells (T reg cells) are central to the maintenance of immune tolerance [1] [2] [3] [4] [5] . T reg cells are produced mainly in the thymus and require expression of the transcription factor Foxp3. Thymic development of T reg cells depends on signals transduced by engagement of the T cell antigen receptor (TCR) with complexes of self peptide and major histocompatibility complex. In addition, costimulatory factors (such as CD28) and cytokines, including interleukin 2 (IL-2) and transforming growth factor-b, contribute to the induction of Foxp3 and thymic development of T reg cells 6, 7 . After their maturation and release into the periphery, T reg cells use diverse mechanisms to mediate immune suppression. These mechanisms include the production of inhibitory cytokines, the modulation of dendritic cell maturation and function and the killing or metabolic disruption of target cells 8 . Although T reg cell activity is essential for immune tolerance and prevention of autoimmunity, the potent T reg cellmediated suppression may abrogate adaptive immune responses and render the host susceptible to infection and cancer. How the development and activity of T reg cells are controlled to establish protective immunity without pathological anti-self reactivity is an open question. Stimulation of antigen-presenting cells through Toll-like receptors has been linked to reversal of the suppressive activity of T reg cells 9, 10 . In addition, direct activation of Toll-like receptors 2 and 8 expressed by T reg cells can also down-modulate T reg cell activity [11] [12] [13] . Despite those studies, precisely how T reg cells are regulated to effect immune function and tolerance remains poorly understood.
Sphingosine 1-phosphate (S1P) is a natural lysophospholipid with micromolar concentrations in the plasma [14] [15] [16] . S1P signals through five known G protein-coupled receptors (S1P 1 -S1P 5 ). FTY720, a member of a new class of immunosuppressants in clinical trials for transplantation tolerance and multiple sclerosis, sequestrates T cells in lymphoid organs by acting on four of the five S1P receptors 17, 18 . Studies using genetic approaches to alter the function of S1P 1 (also called Edg1; A000813) have indicated that S1P 1 is the main S1P receptor that regulates T cell trafficking. T cells from S1P 1 -deficient mice fail to egress from thymus 19, 20 , whereas S1P 1 -transgenic T cells 'preferentially' distribute to the blood rather than lymphoid organs 21, 22 . Thus, S1P 1 is critical for the egress of T cells from lymphoid organs. S1P 1 couples mainly with pertussis toxin-sensitive G i proteins. The main pathways 'downstream' of S1P 1 include activation of the kinase cascades involving Ras-Erk or (PI(3)K)-Akt (Akt1 (A000249), Akt2 (A000250) and Akt3 (A000251)), as well as calcium mobilization and rearrangement of the actin cytoskeleton 23 . S1P 1 is expressed on T reg cells, but its functional importance has not been addressed directly 24 . Given the limitations of the pharmacological inhibitors, we chose to use two complementary genetic approaches, by eliminating and enhancing S1P 1 function selectively in T cells. Our results show that loss of S1P 1 function resulted in enhanced thymic differentiation and suppressive activity of T reg cells. Conversely, greater S1P 1 signaling led to diminished development and function of T reg cells in vitro and in vivo and, more notably, the development of spontaneous autoimmunity due to defects in T reg cells. Thus, S1P 1 negatively regulates both the thymic generation and suppressive activity of T reg cells. We further show that the function of S1P 1 in T reg cells is mediated by the 'downstream' Akt-mTOR pathway. Finally, S1P 1 expression was regulated with different dynamics in T reg cells versus conventional T cells (T conv cells), which suggests that S1P 1 coordinates the responses of T reg cells and T conv cells to effect a productive and self-controlled immune response.
RESULTS

S1P 1 signaling diminishes the thymic T reg population
To investigate the intrinsic function of S1P 1 in T cells, we crossed mice carrying loxP-flanked S1P 1 alleles (S1pr1 fl/fl ) 20 with CD4-Cre-transgenic mice to delete the loxP-flanked S1pr1 alleles specifically in T cells with Cre recombinase (S1P 1 -knockout mice). In contrast to wild-type control mice, S1P 1 -knockout mice had accumulation of mature single-positive thymocytes, and they had considerably fewer T cells in the periphery than did wild-type mice ( Supplementary Fig. 1a online). Real-time PCR analysis indicated efficient deletion of S1pr1 in thymocytes ( Supplementary Fig. 1b ). These findings were consistent with involvement of S1P 1 in thymocyte egress 19, 20 . To assess the requirement of S1P 1 in the development of naturally occurring Foxp3 + T reg cells, we examined the expression of Foxp3 in mature CD4 + single-positive (CD4SP) thymocytes. S1P 1 -knockout mice had more cells in the thymic T reg population that expressed Foxp3 and the immunomodulatory receptors CTLA-4 and GITR than did wild-type mice ( Fig. 1a and Supplementary Fig. 1c ). Thus, S1P 1 deficiency causes expansion of the thymic T reg cell population.
Is S1P 1 sufficient to affect the thymic T reg population? We analyzed two independent lines of transgenic mice expressing S1pr1 under control of the human CD2 promoter-enhancer, which results in higher expression and function of S1P 1 in T cells (S1P 1 -Tg mice) 21 . S1P 1 -Tg mice had considerably fewer thymic Foxp3 + CD4SP cells than did wild-type control mice (Fig. 1b) . As a separate gain-of-function approach, we transduced bone marrow stem cells with retrovirus expressing S1P 1 and implanted them into alymphoid recombinationactivating gene 1-deficient (Rag1 -/-) mice. After reconstitution, the number of Foxp3 + thymocytes expressing S1P 1 was one third that of cells expressing the empty vector (Fig. 1c) . Therefore, greater S1P 1 function diminishes the thymic T reg population.
The defect in S1P 1 -expressing cells in the bone marrow chimeras suggested a cell-autonomous effect of S1P 1 on T reg cells, because the presence of nontransduced cells in the same host failed to 'rescue' the defect by providing necessary trans-acting factors. We further tested that idea by constructing mixed-bone marrow chimeras derived from a 1:1 mixture of wild-type (CD45.1 + ) bone marrow cells and S1P 1 -knockout or S1P 1 -Tg cells (CD45.2 + ) bone marrow cells. S1P 1 -knockout and S1P 1 -Tg cells developed into more and fewer thymic Foxp3 + T reg cells, respectively, compared with the cotransferred CD45.1 + cells (Fig. 1d) . We therefore concluded that S1P 1 has a cell-autonomous effect in inhibiting the thymic T reg population.
S1P 1 inhibits thymic development of T reg cells
The altered thymic T reg cells in S1P 1 -knockout and S1P 1 -Tg mice might have been due to the effects of S1P 1 on the egress or differentiation of T reg cells or both. To distinguish those possibilities, we first analyzed the trafficking of S1P 1 -knockout Foxp3 + CD4SP thymocytes relative to that of Foxp3 -T conv cells. When adoptively transferred, wild-type T conv cells distributed to various lymphoid organs, including the spleen, lymph nodes and blood, whereas S1P 1 -knockout T conv cells were able to enter lymphoid organs but were unable to exit into blood, as reported before 19 . S1P 1 -knockout T reg cells had a defect similar to that of S1P 1 -knockout T conv cells ( Supplementary Fig. 2 online) . Thus, S1P 1 is required for the egress of both T reg and T conv cells, but this function is unlikely to account for the selective population expansion of T reg cells in S1P 1 -knockout thymuses. In further supporting of that proposal, CD4 + CD8 + doublepositive thymocytes, which do not egress into the periphery, had altered Foxp3 + populations in S1P 1 -knockout and S1P 1 -Tg mice ( Supplementary Fig. 1d ).
We used two strategies to directly assess the intrinsic function of S1P 1 in thymic T reg cell differentiation. First, we analyzed Foxp3 + thymocytes in mice 3-5 d after birth, a period critical for the initial generation of T reg cells in wild-type mice, before substantial numbers of T reg cells appear in the periphery 25 . Consequently, the effects of thymocyte emigration are not expected to affect the thymic T reg cell population at this stage. We found the total CD4SP population was not significantly altered in thymuses from neonatal S1P 1 -knockout or S1P 1 -Tg mice ( Supplementary Fig. 3 online) , unlike those in adult mice. However, in these neonatal mice, thymic T reg cells were still altered, with more cells in S1P 1 -knockout thymuses and reciprocally fewer cells in S1P 1 -Tg thymuses ( Supplementary Fig. 3 ). Second, we used fetal thymic organ culture (FTOC), which allows de novo differentiation of thymocytes, including T reg cells, to obviate the effects of differences in thymocyte egress or homing of peripheral T reg cells to the thymus. We cultured thymuses isolated from embryos at embryonic day 16.5 in vitro and found no differences in thymocyte numbers or the distribution of CD4 and CD8 expression among different groups. However, the Foxp3 + CD4SP S1P 1 -knockout population was significantly larger than the Foxp3 + CD4SP wild-type population; conversely, Foxp3 + CD4SP S1P 1 -Tg population was significantly smaller than the Foxp3 + CD4SP wild-type population (Fig. 2a) . These findings collectively demonstrate that S1P 1 serves an intrinsic negative function in thymic T reg cell development. 26, 27 . Notably, the CD4 + CD25 + Foxp3 -population was much smaller in S1P 1 -knockout thymuses but was significantly larger in S1P 1 -Tg thymuses (Fig. 2b) , which suggests that S1P 1 may act on these cells to restrain their further differentiation into mature Foxp3-expressing T reg cells.
To directly test that possibility, we crossed S1P 1 -knockout and S1P 1 -Tg mice with Foxp3 gfp 'knock-in' mice, which express green fluorescent protein (GFP) regulated by the Foxp3 control elements 28 . We sorted thymic CD4 + CD25 + Foxp3 -populations and cultured them with IL-2 or IL-15. In these conditions, we found no significant differences in the apoptosis of these cells (data not shown). Foxp3 induction was much greater in S1P 1 -knockout cells, whereas we found a reciprocal change in S1P 1 -Tg cells regardless of the stimulus or dose used (Fig. 2c) . Therefore, S1P 1 blocks the differentiation of CD4 + CD25 + Foxp3 -cells into mature T reg cells.
Altered homeostasis and function of S1P 1 -knockout T reg cells Our results thus far had identified a negative function for S1P 1 in thymic T reg cell differentiation. We then examined whether S1P 1 affects the homeostasis and suppressive activity of T reg cells in the periphery. In peripheral lymphoid organs of S1P 1 -knockout mice, there was selectively larger T reg population marked by the expression of Foxp3 (Fig. 3a) , CD25, GITR and CTLA-4 ( Fig. 3b ), in line with the thymic alterations. Nonetheless, we were able to isolate only very few S1P 1 -knockout peripheral cells because of the blocked thymocyte egress. For functional studies, we sorted Foxp3 + CD4SP thymocytes, which have a suppressive activity similar to that of peripheral T reg cells 2 . Although S1P 1 deficiency resulted in more Foxp3 + CD4SP cells, Foxp3 expression on a 'per-cell' basis was similar in wild-type and S1P 1 -knockout cells ( Supplementary Fig. 4 online). In an in vitro T cell suppression assay, we assessed the proliferation of the target Foxp3 -T conv cells from wild-type mice in the presence of wild-type or S1P 1 -deficient Foxp3 + thymic T reg cells. S1P 1 -knockout T reg cells showed a significantly greater capacity than wild-type T reg cells to suppress T conv cell proliferation and IL-2 production (Fig. 3c) . We examined the proliferation of T reg cells alone but found no significant proliferation of either wild-type or S1P 1 -knockout Foxp3 + cells (data not shown), which suggested that the difference was not due to the differences in the proliferation of T reg cells. Given the altered differentiation of Foxp3 + cells in the S1P 1 -knockout thymus, it remained possible that the greater suppressive activity of S1P 1 -knockout T reg cells was secondary to defective thymic development. Hence, we transduced T reg cells from the periphery of S1pr1 fl/fl mice with Cre-expressing retrovirus to 'acutely' delete S1pr1 in vitro. Cells with deletion of S1pr1 showed a greater suppressive activity than did Cre-expressing wild-type control cells (Fig. 3d) . In contrast, there was no difference in the suppressive activity of nontransduced (GFP -) cells of either genotype (data not shown). Therefore, S1P 1 deficiency directly potentiates T reg cell suppressive activity.
Impaired suppressive activity of S1P 1 -Tg T reg cells We next sought to determine whether ectopic S1P 1 expression was sufficient to alter T reg cell suppressive activity. In S1P 1 -Tg mice, peripheral T reg populations were mostly normal ( Supplementary  Fig. 5a ,b online), which suggested that compensatory mechanisms in the periphery might overcome defects in thymic development. However, in the chimeras generated by injection of a mixture of wildtype and S1P 1 -Tg bone marrow cells, T reg cells derived from S1P 1 -Tg bone marrow were selectively less abundant than their cotransferred wild-type counterparts ( Supplementary Fig. 5c ). Thus, S1P 1 -Tg T reg cells have a competitive disadvantage in their peripheral maintenance. In T cell suppression assays, S1P 1 -Tg T reg cells were much less efficient at suppressing the responses of T conv cells. Specifically, the proliferation and cell cycle progression of target cells were significantly greater in the presence of S1P 1 -Tg T reg cells than in the presence of wild-type T reg cells (Fig. 4a and Supplementary Fig. 6a online) . Furthermore, S1P 1 -Tg T reg cells had a much lower capacity to inhibit the IL-2 production of target cells ( Supplementary Fig. 6b ). To demonstrate that such an altered T reg activity was a direct result of S1P 1 function rather than being secondary to defective thymic development, we transduced wild-type T reg cells with S1P 1 -expressing retrovirus. Expression of S1P 1 substantially impaired T reg cell suppressive activity (Fig. 4b) , which emphasizes an intrinsic inhibitory effect of S1P 1 on T reg function.
We next used two approaches to investigate whether S1P 1 controls T reg cell suppressive activity in vivo. First, we used a model of colitis induced by the transfer of T conv cells into lymphopenic hosts; this disease can be prevented by the cotransfer of T reg cells 29 (Supplementary Fig. 7a online) . Transfer of wild-type T conv cells resulted in severe weight loss (data not shown), and cotransfer of T reg cells from wildtype prevented loss of body weight, but cotransfer of T reg cells from S1P 1 -Tg mice did not (Fig. 4c) . We killed mice 9-10 weeks after transfer and assessed lesions in the colon and cecum. Recipients of T conv cells and wild-type T reg cells transferred together did not develop prominent colitis, whereas recipients of T conv cells alone and recipients of T conv cells and S1P 1 -Tg T reg cells transferred together developed severe colitis (Fig. 4d,e) . The distribution of T reg cells in the colon and lymphoid organs was similar in groups given wild-type and S1P 1 -Tg T reg cells ( Supplementary Fig. 7b,c) . Thus, S1P 1 -Tg T reg cells did not have obvious defects in population expansion and/or homeostasis in this model, which suggested that the inability of these cells to control colitis was most likely due to their impaired suppressive activity.
Second, we examined the importance of S1P 1 in controlling systemic autoimmune diseases caused by T reg cell deficiency. We constructed mixed-bone marrow chimeras by transferring bone marrow cells from Foxp3-deficient scurfy (sf) mice and S1P 1 -Tg or wild-type mice into Rag1 -/-recipients. In the resulting chimeras, only the S1P 1 -Tg or wildtype bone marrow cells could give rise to Foxp3 + T reg cells (Supplementary Fig. 8a online) . In the chimeras that received sf bone marrow alone, T cells were overtly activated and there was prominent inflammation and lymphocytic infiltration in the liver, lung and colon. In contrast, chimeras that received sf and wild-type bone marrow cells showed minimal T cell activation and tissue inflammation. Notably, chimeras that received sf and S1P 1 -Tg bone marrow cells showed profound T cell activation and inflammatory disease that were indistinguishable from those of chimeras that received sf bone marrow cells alone ( Supplementary Fig. 8b,c) . Thus, S1P 1 -Tg T reg cells fail to mediate immune tolerance in vivo.
Defects in S1P 1 -Tg T reg cells cause autoimmunity The impaired suppressive activity of T reg cells from S1P 1 -Tg mice prompted us to examine whether homeostasis of the immune system was altered in these mice. S1P 1 -Tg mice had more activated CD62L lo CD44 hi effector or memory T cells; this became more prominent as the mice aged (Fig. 5a) . Furthermore, T conv cells from S1P 1 -Tg mice, even those at a young age, were hyperproliferative in response to TCR stimulation (Fig. 5b) , which suggested they had a lower threshold for activation. To determine whether this resulted in altered self-tolerance, we measured autoantibodies in the mice. We found higher titers of anti-nuclear antibody and antibody to doublestranded DNA in serum from older S1P 1 -Tg mice (Fig. 5c) , which was indicative of autoimmune reactions. Because a predominant T helper type 1 (T H 1) cytokine response, especially interferon-g (IFN-g), is associated with the pathogenesis of lupus, a prototypical systemic autoimmune disease 30 , we determined whether activated T cells in S1P 1 -Tg mice differentiated into a T H 1 phenotype. S1P 1 -Tg cells produced more IFN-g but less IL-4 than did control cells (Fig. 5d) . Consistent with that, serum titers of T H 1-dependent immunoglobulin G2a, but not T H 2-dependent immunoglobulin G1, were significantly higher in S1P 1 -Tg mice (Fig. 5e) . Thus, greater S1P 1 signaling in T cells leads to their spontaneous activation and differentiation into a T H 1 phenotype and breakdown of immune tolerance. We reasoned that the autoimmunity in S1P 1 -Tg mice could have been due to an intrinsic defect in T conv cells or impaired suppressive activity of T reg cells. To distinguish between those possibilities, we generated bone marrow chimeras by transferring wild-type and S1P 1 -Tg bone marrow cells alone or in combination into Rag1 -/-mice. As expected, T cells from mice given S1P 1 -Tg bone marrow alone were spontaneously activated and hyper-responsive to TCR stimulation (data not shown). In contrast, in the mixed chimeras containing both S1P 1 -Tg and wild-type cells, S1P 1 -Tg T conv cells were not spontaneously activated or hyper-responsive to TCR stimulation, and they produced normal amounts of IFN-g and IL-4 ( Fig. 5f-h) . Therefore, activation of T conv cells in S1P 1 -Tg mice was non-cell autonomous and could be 'rescued' by the presence of wild-type cells. Next we determined whether providing S1P 1 -Tg mice with wild-type T reg cells alone could prevent the T cell-activation phenotype. We injected 3-day-old S1P 1 -Tg mice with wild-type T reg cells, a condition that results in the repopulation of donor T reg cells 31 . After neonatal transfer of T reg cells into S1P 1 -Tg mice, T conv cells in the recipients showed normal homeostasis and proliferation ( Supplementary Fig. 9 online). We concluded that the impaired T reg cell compartment in S1P 1 -Tg mice accounted for their disrupted immune homeostasis.
S1P 1 signals through Akt-mTOR to affect T reg cells
To investigate the mechanisms that mediate S1P 1 function, we stimulated thymic T reg precursors (CD4 + CD25 + Foxp3 -) with IL-2, which induced their differentiation into T reg cells 26 (Fig. 2c) . We assessed the activation of IL-2 'downstream' pathways, including Akt, Erk and transcription factor STAT5, by flow cytometry analysis of phosphorylated proteins. As expected, IL-2 activated all three pathways in wild-type T reg precursors. In contrast, S1P 1 -Tg cells activated the Erk and STAT5 pathways like wild-type cells did but showed much more activation of Akt and phosphorylation of S6 ribosomal protein, a well established target of the Akt-mTOR pathway (Fig. 6a) .
Akt has been shown to inhibit Foxp3 induction in vitro and after thymic injection 32, 33 . Does greater Akt activity mediate the S1P 1 functions in T reg differentiation? To investigate this, we stimulated wild-type and S1P 1 -Tg thymic T reg precursors with IL-2 in the presence of LY294002 (an inhibitor of PI(3)K 'upstream' of Akt) or rapamycin (an inhibitor of mTOR 'downstream' of Akt). LY294002 and rapamycin potentiated Foxp3 induction of S1P 1 -Tg T reg precursors similar to wild-type cells (Fig. 6b) . Treatment with additional inhibitors of PI(3)K or mTOR, including PI-103 and NVP-BEZ235 (ref. 34) , had effects similar to those of rapamycin in restoring the T reg differentiation of S1P 1 -Tg cells ( Supplementary Fig. 10 online) , which indicated specific involvement of the Akt-mTOR pathway in S1P 1 signaling. In contrast, treatment with U0126 (an inhibitor of Erk) did not affect T reg differentiation (Fig. 6b) . Therefore, the higher Akt activity in S1P 1 -Tg T reg precursors results in their defective differentiation.
Next we identified the signaling pathways activated by higher S1P 1 expression in peripheral T reg cells. After stimulation with IL-2, peripheral T reg cells from S1P 1 -Tg mice showed normal activation of Erk and STAT5 but more phosphorylation of Akt and S6 ribosomal protein (Fig. 6c) . We found a similar pattern when we stimulated S1P 1 -Tg T reg cells with antibody to CD3 (anti-CD3) plus anti-CD28 ( Supplementary Fig. 11 online) . We then treated peripheral S1P 1 -Tg T reg cells with pharmacological inhibitors and found that LY294002, rapamycin, PI-103 and NVP-BEZ235 enhanced the suppressive activity of these cells similar to that of wild-type T reg cells treated in a similar way, but U0126 did not ( Supplementary Fig. 12 online) . Moreover, blocking Akt activation through the expression of dominant negative Akt in S1P 1 -Tg cells completely restored their suppressive activity (Fig. 6d) . We concluded that more S1P 1 function led to excessive Akt activity, which accounted for the impaired differentiation and function of T reg cells.
S1P 1 is necessary for Akt activation in T reg cells
Although the results reported above indicated that S1P 1 was sufficient to activate the Akt pathway to antagonize the development and function of T reg cells, it remained unclear whether S1P 1 was necessary for Akt activation in T reg cells. To address that issue, we stimulated T reg precursors from wild-type or S1P 1 -knockout mice with IL-2. S1P 1 -knockout cells showed much less Akt phosphorylation but no change in STAT5 or Erk after IL-2 stimulation, compared with wild-type cells (Fig. 7a) . Similarly, S1P 1 deficiency resulted in less Akt activation in mature thymic T reg cells (Fig. 7b) . Moreover, after 'acute' deletion of S1P 1 from peripheral T reg cells in vitro, less Akt activation resulted after stimulation with IL-2 or with anti-CD3 plus anti-CD28 (Supplementary Fig. 13a,b online) . Therefore, S1P 1 is needed to mediate IL-2-and TCR-induced activation of Akt in T reg cells. In addition to S1P 1 , T reg cells also express all of the other four receptors for S1P 24 . Exposure of T cells to S1P results in the activation of Akt 35 , although whether this is mediated by S1P 1 is not known. We treated wild-type and S1P 1 -deficient T reg cells with S1P and examined the 'downstream' signaling pathways. In both thymic Foxp3 + CD4SP cells and peripheral T reg cells, after 'acute' deletion of S1P 1 , activation of Akt but not of Erk was much lower than in their wild-type counterparts ( Supplementary Fig. 13c ). Thus, among the S1P receptors, S1P 1 is important in mediating S1P-induced activation of Akt in T reg cells.
We then determined whether the lower Akt activity accounted for the enhanced suppressive activity of S1P 1 -knockout T reg cells. We transduced T reg cells from S1pr1 fl/fl mice with Cre-GFP retrovirus to delete S1pr1, together with retrovirus expressing constitutively active Akt (marked by the coexpressed Thy-1.1 molecule). Constitutive activation of Akt resulted in slightly lower suppressive activity of wild-type T reg cells but much lower suppressive activity of S1P 1 -deficient T reg cells (Fig. 7c) . Therefore, the lower Akt activity was responsible for the enhanced suppressive activity of S1P 1 -knockout T reg cells.
Function and signaling of S1P 1 in T conv cells Our data reported above indicated that S1P 1 , by activating Akt, negatively regulates the development and function of T reg cells. What are the function and signaling mechanisms of S1P 1 in T conv cells? Using mixed-bone marrow chimeras and neonatal transfer of T reg cells (Fig. 5f-h and Supplementary Fig. 9 ), we did not find an intrinsic defect in T conv cells from S1P 1 -Tg mice. To further extend our observations, we used retroviral systems to ectopically express S1P 1 or delete S1pr1 in Foxp3 -T conv cells but did not find altered proliferation of these cells ( Supplementary Fig. 14a,b online) . Moreover, anti-CD3 induced similar degrees of proliferation of Foxp3 -CD4SP thymocytes from wild-type and S1P 1 -knockout mice ( Supplementary Fig. 14c ). Thus, S1P 1 does not affect the proliferative response of T conv cells.
To address the signaling mechanisms of S1P 1 in T conv cells, we activated wild-type and S1P 1 -Tg T conv cells with IL-2 or with anti-CD3 plus anti-CD28. Activation of Akt, Erk and STAT5 was similar in these cells ( Supplementary Fig. 15 online) . Similarly, in S1P 1 -deficient T conv cells, IL-2 and TCR induced normal activation of Akt (Supplementary Fig. 16a,b online) . Thus, unlike its requirement in T reg cells, S1P 1 is dispensable for TCR-or IL-2-induced activation of Akt in T conv cells. To ensure that T conv cells have no general defects in S1P 1 signaling, we stimulated S1P 1 -sufficient and S1P 1 -deficient T conv cells with S1P. S1P 1 deficiency resulted in less S1P-induced activation of Akt ( Supplementary Fig. 16c ). Therefore, whereas T conv cells use S1P 1 to mediate Akt activation in response to S1P, the activation of Akt in response to TCR or IL-2 occurs independently of S1P 1 in these cells.
The differences in the function of S1P 1 in T reg cells and T conv cells prompted us to examine whether S1P 1 expression differs in these T cell subsets. We detected S1pr1 mRNA in various cells of the immune system, including T reg cells and T conv cells ( Supplementary  Fig. 17 online) . After stimulation with TCR and IL-2, S1pr1 mRNA decreased abruptly in T conv cells, as reported before 21, 22 , whereas it was downregulated gradually in T reg cells (Fig. 8a) . Expression of KLF2, a transcription factor essential for S1P 1 expression in thymocytes 36 , showed a pattern similar to that of S1P 1 ( Supplementary Fig. 18 online), which suggests that KLF2 contributes to the differences in the regulation of S1P 1 in peripheral T reg cells and T conv cells. To determine whether this different regulation of S1P 1 occurs in vivo, we transferred ovalbumin-specific OT-II TCR-transgenic T reg cells and T conv cells into wild-type hosts, followed by antigen immunization. At 2 d after in vivo activation, downregulation of S1pr1 was much more pronounced in T conv cells than in T reg cells (Fig. 8b) . These findings indicate that S1P 1 function and expression are regulated differently in T reg cells and T conv cells. We propose that dynamic regulation of S1P 1 expression contributes to lymphocyte priming and the maintenance of immune homeostasis ( Supplementary Fig. 19 online) .
DISCUSSION
Work on T reg cell biology has focused mainly on the mechanisms of T reg cell-mediated immune suppression 4, 8 . How the development and function of T reg cells are regulated remains poorly understood. Here we report that S1P 1 is an intrinsic negative regulator of the thymic differentiation, peripheral maintenance and suppressive activity of T reg cells and that such functions are mediated by the 'downstream' AktmTOR pathway. To our knowledge, S1P 1 is the first receptor found to negatively regulate these diverse physiological processes of T reg cells. Moreover, among the regulatory mechanisms in T reg cells, the S1P 1 pathway is unique in that it couples the trafficking and intrinsic development and function of T reg cells and coordinates the immune responses mediated by T reg cells and T conv cells. Using mouse models with deficient and enhanced S1P 1 functions, we have identified an inhibitory function for S1P 1 on the thymic T reg population. Although S1P 1 facilitated thymic egress of T reg cells, an intrinsic function for S1P 1 in blocking thymic T reg differentiation was demonstrated by our analyses of neonatal thymuses and FTOCs and, more notably, of the CD4 + CD25 + Foxp3 -population. Such a population has been postulated to act as precursors for thymic T reg cells, although genetic evidence of this is lacking 26 . The reciprocity of the alterations in CD4 + CD25 + Foxp3 -and CD4 + CD25 + Foxp3 + populations in both S1P 1 -knockout and S1P 1 -Tg mice provides key genetic evidence supporting the definition of CD4 + CD25 + Foxp3 -cells as T reg precursors 26 . Collectively, these findings demonstrate that S1P 1 delivers a crucial negative signal for the thymic development of T reg cells. Studies have shown that S1P 1 expression is upregulated during thymocyte maturation 19 . Such upregulation in T reg cells probably serves as a molecular 'switch' to restrain the differentiation of T reg cells (thus maintaining a proper balance between the T reg and T conv populations) and to facilitate their release to the periphery, thereby coordinating the development and egress of T reg cells in the thymus.
Once T reg cells are released from thymus into secondary lymphoid organs, they modulate immunity to both self and foreign antigens. However, excessive T reg cell-mediated suppression may render the host susceptible to infection and cancer. Signaling through Toll-like receptors expressed in T reg cells or dendritic cells has been linked to the negative control of T reg cell suppressive activity [9] [10] [11] [12] 37 , although the mechanisms of action for this remain unclear. Using many in vitro and in vivo systems, we have demonstrated that S1P 1 is a critical negative regulator of T reg cell function. Furthermore, both naive T reg cells and T conv cells have high expression of S1P 1 . At an early stage of immune activation, S1P 1 expression is maintained mainly in T reg cells, which results in the low suppressive activity and high mobility of these cells. This serves to prevent premature T reg cell-mediated suppression for the initiation of an immune response. In contrast, S1P 1 is rapidly and profoundly downregulated in T conv cells to mediate their sequestration in the draining lymph nodes to engage in efficient interaction with antigen-presenting cells 19, 21 . The overall function of S1P 1 in T reg cells and T conv cells at this stage is to promote a productive immune response. At a late stage of immune activation, S1P 1 is downregulated in T reg cells to release T reg cell-mediated suppression, thereby preventing an exuberant immune response caused by T conv cells. In contrast, S1P 1 slowly recovers in T conv cells to allow their egress into peripheral tissues 19, 38 . It remains unclear how T reg cell-mediated suppression is attenuated during acute infection to establish protective immunity 9, 11, 39, 40 ; our findings suggest that coordination of T reg and T conv responses by S1P 1 is crucial for a productive and self-controlled immune response.
To identify the molecular mechanisms that mediate the functions of S1P 1 in T reg cells, we examined signaling pathways activated by S1P 1 . We found a specific function for S1P 1 in the activation of Akt, but not of Erk or STAT5, in thymic T reg precursors and mature T reg cells after TCR or IL-2 stimulation. Notably, the Akt-mTOR pathway has been linked to blockade of T reg differentiation 32, 33 , but the cellular factors responsible for activating Akt have not been established. Our studies have identified S1P 1 as a key receptor that activates Akt-mTOR. Notably, restoration of proper Akt-mTOR activity corrected the defects caused by S1P 1 loss and gain of function. Therefore, activation of Akt-mTOR by S1P 1 mediates the negative effects of S1P 1 on the development and function of T reg cells.
We further identified a fundamental difference in S1P 1 signaling in T reg cells and T conv cells. S1P 1 did not affect the T conv cell proliferative response and was dispensable for IL-2-or TCR-induced activation of Akt in T conv cells, unlike its effect in T reg cells. In contrast, S1P 1 was required for Akt activation in response to S1P stimulation in both T reg cells and T conv cells. It seems that S1P 1 is selectively coupled to TCR and cytokine receptors for the activation of Akt signaling in T reg cells but not in T conv cells. In support of this model, transactivation of S1P 1 by growth factor receptors has been reported with distinct mechanisms in a cell context-specific way 41 . Notably, T conv cells and T reg cells differ in their ability to activate Akt in response to TCR and IL-2 stimulation 42, 43 , and our studies of S1P 1 further highlight the distinct mechanisms of Akt signaling in these two T cell subsets.
In addition to S1P 1 , T reg cells also express all of the other four receptors for S1P 24 , whose the expression was not substantially altered in S1P 1 -knockout and S1P 1 -Tg T reg cells (data not shown). Whether and how S1P 1 interacts with its natural ligand S1P in T reg cells will be an important area of investigation. FTY720, a member of the new generation of immunosuppressive drugs that target S1P 1 , has been shown to enhance T reg cell activity 24, 44, 45 . These effects caused by FTY720 seem to be similar to S1P 1 deficiency, which suggests that FTY720 may act as an antagonist to inactivate S1P 1 in T reg cells. However, mechanisms of action of FTY720 are complex, because it can serve as an agonist for four of the five known S1P receptors 17, 18 . Moreover, FTY720 has immunomodulatory activities independent of S1P receptors 46 . Given the limitations of the pharmacological approaches, we used genetic systems to specifically target the S1P 1 pathway in T cells and have unequivocally shown an intrinsic negative function for S1P 1 in the development and function of T reg cells.
In summary, S1P 1 delivers a key negative signal for the development, maintenance and function of T reg cells. The function of S1P 1 is mediated mainly by Akt-mTOR in T reg cells. Our studies have emphasized that T reg cells are regulated by more than surface expression of TCR and costimulatory molecules and limited production of cytokines. Instead, the development and function of these cells are further shaped by an abundant circulatory lipid. Notably, FTY720 and rapamycin, two new promising immunosuppressants for transplantation and autoimmune disease, target S1P 1 and Akt-mTOR, respectively. Our studies suggest that a shared mechanism may contribute to the immunomodulatory functions of these drugs. The S1P 1 -Akt-mTOR pathway in T reg cells may be explored for the development of new therapeutics for autoimmunity, cancer and infection.
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Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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ONLINE METHODS
Mice and bone marrow chimeras. S1pr1 fl mice 20 , CD4-Cre mice 47 , S1P 1 -Tg mice 21 and Foxp3 gfp 'knock-in' mice 28 have been described and were backcrossed to the C57BL/6 background extensively. Wild-type controls for S1P 1 -knockout mice (CD4-Cre;S1pr1 fl/fl ) included Cre + mice (CD4-Cre;S1pr1 +/+ ) to account for the effects of Cre; controls for S1P 1 -Tg mice were transgenenegative littermates. C57BL/6, CD45.1, Thy-1.1, Rag1 -/-, OT-II and sf mice (all on a C57BL/6 background) were from the Jackson Laboratory. Mice 6-10 weeks of age were used unless otherwise noted. Bone marrow chimeras were generated by transfer of bone marrow depleted of T cells (1 Â 10 7 to 2 Â 10 7 bone marrow cells) into sublethally irradiated (5 Gy) alymphoid Rag1 -/-mice as described 47 . All mice were kept in specific pathogen-free conditions in the Animal Resource Center at St. Jude Children's Research Hospital. Animal protocols were approved by Institutional Animal Care and Use Committee of St. Jude Children's Research Hospital.
Cell purification and flow cytometry. Lymphocytes were isolated from the thymuses spleens and lymph nodes of mice and were sorted on a MoFlo (Beckman-Coulter) or Reflection (i-Cyt). T reg cells and T conv cells were sorted on the basis of being CD4 + CD45RB lo CD25 + and CD4 + CD45RB hi CD25 -, respectively; alternatively and wherever possible, mice crossed with Foxp3 gfp 'knock-in' mice were used, from which CD4 + CD45RB lo GFP + and CD4 + CD45RB hi GFP -populations were sorted for T reg cells and T conv cells, respectively. For flow cytometry analysis of surface markers, cells were stained with antibodies (all from eBioscience) in PBS containing 2% (wt/vol) BSA. Intracellular Foxp3 (FJK-16s; eBioscience), CTLA-4 (UC10-4F10-11; BD Biosciences), IFN-g (XMG1.2; BD Biosciences) and IL-4 (11B11; BD Biosciences) were analyzed by flow cytometry according to the manufacturer's instructions. For detection of phosphorylated signaling proteins, purified cells were activated with IL-2 or with anti-CD3 (145-2C11; BD Biosciences) and anti-CD28 (37.51; BD Biosciences), were immediately fixed with Phosflow Perm buffer (BD Biosciences), were made permeable with Phosflow Lyse/Fix buffer (BD Biosciences) and were stained with phycoerythrin or allophycocyanin directly conjugated to antibody to Akt phosphorylated at Ser 473 (D9E; Cell Signaling Technology), Erk phosphorylated at Thr202 and Tyr204 (20A; BD Biosciences), STAT5 phosphorylated at Tyr694 (47; BD Biosciences) or S6 phosphorylated at Ser235 and Ser236 (D57.2. 2E; Cell Signaling Technology). Flow cytometry data were acquired on an upgraded five-color FACScan (Becton Dickinson), and were analyzed with FlowJo software (Treestar). Cell numbers of various populations were calculated by multiplication of the total cell number by the percentages of each individual population from the same mouse, followed by averaging.
T cell culture, activation and T reg cell suppression assays. T cells were cultured in Bruff's medium supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin as described 47 . For measurement of T cell activation, sorted T conv cells (5 Â 10 4 ) were cultured in 96-well flat-bottomed plates and were stimulated for 72 h with various doses of anti-CD3 (145-2C11) and/or anti-CD28 (37.51) in the presence of irradiated splenocytes as antigenpresenting cells. For in vitro T cell suppression assays, sorted T conv cells (5 Â 10 4 ) and T reg cells (at various ratios with T conv cells) were cultured for 72 h in 96-well flat-bottomed plates along with anti-CD3 (2 mg/ml; 145-2C11) and irradiated splenocytes. T cell proliferation was determined by pulsing of cells with [ 3 H]thymidine at a dose of 1 mCi per well for the final 12-16 h of culture or by labeling with CFSE (carboxyfluorescein diacetate succinimidyl diester) according to the manufacturer's protocols (Invitrogen-Molecular Probes). IL-2 production was analyzed by Bioplex assay (BioRad). For drug treatment, cells were preincubated with vehicle, 5 mM U0126, 10 mM Ly294002 or 100 nM rapamycin (all from Calbiochem) for 30 min before stimulation.
Retroviral transduction. S1pr1 and Cre cDNAs were cloned into the MSCV retroviral vector upstream of an expression cassette for internal ribosome entry site and GFP. Retroviral constructs expressing dominant negative Akt or constitutively active Akt with a linked Thy-1.1 marker (MiT) 48 were provided by David Hildeman (University of Cincinnati). Phoenix-Eco packaging cells were transfected with Lipofectamine (Invitrogen) and recombinant retrovirus was collected 48 and 72 h after transfection. T reg cells were stimulated for 48 h with 5 mg/ml of anti-CD3 (145-2C11), 5 mg/ml of anti-CD28 (37.51) and 100 U/ml of IL-2 and then were transduced with retroviruses by 'spin inoculation' (650g for 1 h) as described 47 . Cells were cultured for an additional 5 d before being sorted according to expression of GFP or Thy-1.1 and were used for assays of T cell suppression. Deletion of S1pr1 by Cre expression in S1pr1 fl/fl cells was confirmed by quantitative PCR analysis (data not shown). In some experiments, double transduction was used in which T reg cells were transduced with Cre-GFP retrovirus at 48 h and then with empty MiT vector or MiT expressing constitutively active Akt retrovirus 6 h later. For transduction of bone marrow stem cells, mice were injected with 5-fluorouracil (0.15 mg/g) and were killed 2 d later. Bone marrow cells were collected and their populations were expanded for 2 d with IL-6 (50 ng/ml; R&D Systems), IL-3 (20 ng/ml; R&D Systems) and stem cell factor (50 ng/ml; R&D Systems) before they were transduced with retrovirus as described above. At 24 h after transduction, cells were collected and were injected into irradiated Rag1 -/-mice.
Measurement of serum antibodies. Titers of autoantibodies and immunoglobulin subclasses were measured with kits from Alpha Diagnostic International and Southern Biotechnology Associates, respectively.
FTOC. Fetal thymus lobes were dissected from embryos at embryonic day 16.5 and were cultured for approximately 7 d on sponge-supported filter membranes at an interface between 5% CO2-humidified air and T cell culture medium for induction of thymocyte differentiation. The cell culture medium contained undetectable numbers of thymocytes (data not shown).
In vivo migration assays. Purified CD4SP thymocytes from wild-type or S1P 1 -knockout mice were labeled with CFSE, were mixed with approximately same numbers of control wild-type cells (Thy-1.1 + ) and were transferred into C57BL/6 recipient mice (Thy-1.2 + ). The cotransferred Thy-1.1 + cells served as an internal control for normalization of the transfer and detection efficiencies among different recipients. At 24 h, lymphocytes were prepared from blood, spleen, peripheral lymph nodes and Peyer's patches of recipient mice and were stained with anti-Foxp3 (FJK-16s; eBioscience), anti-Thy-1.1 (HIS51; eBioscience) and anti-CD4 (RM4-5; eBioscience). Donor experimental cells, cotransferred internal control cells and recipient CD4 + T cells were distinguished by being CFSE + Thy-1.2 + , CFSE -Thy-1.1 + and CFSE -Thy-1.2 + , respectively. Donor experimental cells were further categorized as Foxp3 -T conv cells and Foxp3 + T reg cells. Results are presented as the ratio of wild-type or S1P 1 -knockout T cells to the cotransferred Thy-1.1 + internal control cells as described 21 .
Neonatal transfer of T reg cells. T reg cells (CD45.1 + ) were injected intraperitoneally into 3-day-old wild-type and S1P 1 -Tg neonatal mice (CD45.2 + ). At 8 weeks after transfer, recipient T lymphocytes were analyzed by staining of the congenic markers CD45.1 and CD45.2.
Colitis model. Rag1 -/-mice were injected intraperitoneally with 4 Â 10 5 T conv cells (CD45.1 + ) alone or in combination with 2 Â 10 5 T reg cells (CD45.2 + ) cells. Mice were weighed and assessed for clinical signs of colitis weekly and were killed 9-10 weeks after transfer. Colons were sectioned, fixed in 10% (vol/vol) neutral buffered formalin and processed routinely, and sections 4 mm in thickness were stained with hematoxylin and eosin or with Alcian blueperiodic acid Schiff. T cells were visualized with a goat polyclonal anti-CD3 antiserum (Santa Cruz) and diaminobenzidine chromagen with hematoxylin as a counterstain. T reg cells were visualized with rat anti-Foxp3 (FJK-16s; eBioscience). Colon pathology was assigned scores by an experienced pathologist (K.B.) 'blinded' to sample identity, according to a semiquantitative scale of 0-5 as follows: grade 0, no changes; grade 1, minimal inflammatory infiltrates present in the lamina propria with or without mild mucosal hyperplasia; grade 2, mild inflammation in the lamina propria with occasional extension into the submucosa, focal erosions, minimal to mild mucosal hyperplasia and minimal to moderate mucin depletion; grade 3, mild to moderate inflammation in the lamina propria and submucosa occasionally transmural with ulceration and moderate mucosal hyperplasia and mucin depletion; grade 4, marked inflammatory infiltrates commonly transmural with ulceration, marked mucosal hyperplasia and mucin depletion, and multifocal crypt necrosis; and grade 5, marked transmural inflammation with ulceration,
